Comparison of the efficacy of ACDF in the treatment of cervical spondylotic myelopathy using 3D printed intervertebral fusion cage and polyetherketone intervertebral fusion cage

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400090439

Enrollment

Unknown

Registered

2024-09-30

Start date

2018-04-21

Completion date

Unknown

Last updated

2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylotic myelopathy

Interventions

New Technology Group:Using 3D printed intervertebral fusion cage

Control group:Using polyetherketone intervertebral fusion cage

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Adult CSM patients aged 18-75 years; ? Patients requiring single-level or double-level anterior cervical discectomy decompression bone graft fusion internal fixation (ACDF).

Exclusion criteria

Exclusion criteria: ? Patients with serious diseases of liver, kidney, brain, cardiovascular, respiratory and endocrine systems who cannot afford surgery; ? With local or systemic infection; ? Osteoporosis, patients with bone mineral density T =-2.5; ? Those who are allergic to the implants in this study (titanium or polyether ether ketone).

Design outcomes

Primary

Measure	Time frame
JOA score;Vertebral height of fusion segment changes;Cobb angle;Prosthesis subsidence rate;	—

Secondary

Measure	Time frame
Operative Complication;Intraoperative Blood Loss;Time of Operation;	—

Countries

China

Contacts

Public ContactYuwei Li

Luohe Central Hospital

460910316@qq.com+86 139 4986 8369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026